Application 020192
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LAMISIL | TERBINAFINE HYDROCHLORIDE | CREAM;TOPICAL | 1% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020192-001 | LAMISIL | TERBINAFINE HYDROCHLORIDE | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | 1992-12-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N020192-001 | LAMISIL | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | 1992-12-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N020192-001 | LAMISIL | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | 1992-12-30 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020192-001 | LAMISIL | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | 1992-12-30 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020192-001 | LAMISIL | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | 1992-12-30 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| terbinafine hydrochloride | TERBINAFINE HYDROCHLORIDE | REMEDYREPACK INC. | 2886b2ff-815f-4621-bc28-1fea082c1920 | 2026-07-09 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Athlete Foot Cream | TERBINAFINE HYDROCHLORIDE | Beautivity LLC | 3b2c1d7f-32c3-aa3b-e063-6394a90a6267 | 2026-06-29 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Scholl's Wellness Company LLC | 31f59302-eaee-211b-e063-6294a90a08b0 | 2026-04-03 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | American Health Packaging | 4ee1b667-0cf6-46e4-a740-4fc27904d577 | 2026-03-06 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 92b31fc4-0f02-4857-b11f-49b9f942ee84 | 2026-02-20 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | REMEDYREPACK INC. | 44c6f6e7-e0c0-450e-83ce-1ed4f3efddec | 2026-02-13 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Northwind Health Company, LLC | ab6f50a5-87ce-0819-e053-2a95a90a22b7 | 2026-01-01 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | A-S Medication Solutions | 5de4c245-7086-453b-b90a-7a1242ec2c0b | 2025-12-18 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT | TERBINAFINE HYDROCHLORIDE | Karo Healthcare Inc. | 21f1bf77-4338-4b75-b513-80a0d98a722a | 2025-12-12 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT | TERBINAFINE HYDROCHLORIDE | Karo Healthcare Inc. | d3e75665-e2d4-47d9-baaa-93817b5fbf00 | 2025-12-12 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Walgreens Athletes Foot | TERBINAFINE HYDROCHLORIDE | Walgreen Company | d706c56f-0123-4a5a-8c85-240cbe6ef7a5 | 2025-11-26 | Warnings | TERBINAFINE HYDROCHLORIDE |
| CVS | TERBINAFINE HYDROCHLORIDE | CVS Pharmacy | 17684ba2-3c2c-4259-84fa-3833f19e5a4d | 2025-11-25 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Golden State Medical Supply, Inc. | b43e4644-024c-4aa6-b403-19152c785802 | 2025-11-25 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT Cream | TERBINAFINE HYDROCHLORIDE | Voyant Beauty Inc. | 9dea4789-bf1c-1577-e053-2a95a90a5381 | 2025-11-18 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Good Neighbor Pharmacy | TERBINAFINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 0a9e890c-1eed-4fde-a484-852a4dd135c2 | 2025-10-17 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2df111dc-ecac-4161-9e22-38436eb37c1f | 2025-10-17 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 747fdc13-7c3a-4672-b50c-31c51037bda2 | 2025-10-14 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT Cream | TERBINAFINE HYDROCHLORIDE | Karo Healthcare Inc. | 1aa5e03a-432b-4154-ab6e-6dbce7a67109 | 2025-10-02 | Warnings | TERBINAFINE HYDROCHLORIDE |
| CVS Pharmacy Athletes Foot | TERBINAFINE HYDROCHLORIDE | CVS Pharmacy | 98a4ed66-2813-49de-8cda-94c41cc3ca9f | 2025-09-25 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Athletes Foot | TERBINAFINE HYDROCHLORIDE | Publix Super Markets Inc. | 58293d62-089d-49ab-b691-dfd705ac9a9c | 2025-09-25 | Warnings | TERBINAFINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.